SAPAMAX Trademark

Trademark Overview

On Monday, August 24, 2009, a trademark application was filed for SAPAMAX with the United States Patent and Trademark Office. The USPTO has given the SAPAMAX trademark a serial number of 79073182. The federal status of this trademark filing is ABANDONED - AFTER INTER-PARTES DECISION as of Wednesday, February 8, 2012. This trademark is owned by Cyclacel Limited. The SAPAMAX trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations and biopharmaceuticals for the treatment of cancer
sapamax

General Information

Serial Number79073182
Word MarkSAPAMAX
Filing DateMonday, August 24, 2009
Status604 - ABANDONED - AFTER INTER-PARTES DECISION
Status DateWednesday, February 8, 2012
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, April 6, 2010

Trademark Statements

Goods and ServicesPharmaceutical preparations and biopharmaceuticals for the treatment of cancer

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code8 - Abandoned
Class Status DateWednesday, February 8, 2012
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameCyclacel Limited
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressGB
Party NameCyclacel Limited
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressGB

Trademark Events

Event DateEvent Description
Thursday, October 15, 2009SN ASSIGNED FOR SECT 66A APPL FROM IB
Tuesday, October 20, 2009APPLICATION FILING RECEIPT MAILED
Tuesday, November 10, 2009ASSIGNED TO EXAMINER
Thursday, November 12, 2009NON-FINAL ACTION WRITTEN
Friday, November 13, 2009REFUSAL PROCESSED BY MPU
Friday, November 13, 2009NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Friday, October 16, 2009NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, November 13, 2009NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Friday, December 11, 2009REFUSAL PROCESSED BY IB
Friday, January 22, 2010PAPER RECEIVED
Monday, February 22, 2010ASSIGNED TO LIE
Thursday, February 25, 2010CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, February 25, 2010AMENDMENT FROM APPLICANT ENTERED
Monday, March 1, 2010LAW OFFICE PUBLICATION REVIEW COMPLETED
Wednesday, March 17, 2010NOTICE OF PUBLICATION
Tuesday, April 6, 2010PUBLISHED FOR OPPOSITION
Monday, May 3, 2010EXTENSION OF TIME TO OPPOSE RECEIVED
Tuesday, October 5, 2010OPPOSITION NOTICE (IB REFUSAL) CREATED
Tuesday, October 5, 2010OPPOSITION NOTICE (IB REFUSAL) SENT TO IB
Wednesday, October 6, 2010OPPOSITION INSTITUTED NO. 999999
Wednesday, February 8, 2012OPPOSITION TERMINATED NO. 999999
Wednesday, February 8, 2012OPPOSITION SUSTAINED NO. 999999
Wednesday, February 8, 2012ABANDONMENT - AFTER INTER PARTES DECISION
Wednesday, February 8, 2012ABANDONMENT NOTICE MAILED - INTER PARTES DECISION
Friday, February 8, 2013FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Friday, February 8, 2013FINAL DISPOSITION NOTICE SENT TO IB
Thursday, February 25, 2010APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, November 9, 2010REFUSAL PROCESSED BY IB
Sunday, March 3, 2013FINAL DECISION TRANSACTION PROCESSED BY IB
Friday, March 30, 2018NEW REPRESENTATIVE AT IB RECEIVED
Thursday, September 12, 2019INTERNATIONAL REGISTRATION RENEWED
Friday, May 24, 2024NEW REPRESENTATIVE AT IB RECEIVED

Related Keywords

sapamax cancer treatment biopharmaceuticals preparations pharmaceutical